Cystic Fibrosis Facts, Management and Advances

Cystic fibrosis, a genetic disorder in children and young adults, is a multisystemic disease that mainly affects the lungs. Advances and improvements in the diagnosis and management of this condition have led to increased overall and symptom-free survival in cystic fibrosis patients. This book exami...

Full description

Bibliographic Details
Main Author: Mohite, Prashant
Other Authors: Reed, Anna, Simon, André R.
Format: eBook
Language:English
Published: IntechOpen 2021
Subjects:
Online Access:
Collection: Directory of Open Access Books - Collection details see MPG.ReNa
LEADER 01637nma a2200337 u 4500
001 EB002205760
003 EBX01000000000000001342961
005 00000000000000.0
007 cr|||||||||||||||||||||
008 240502 ||| eng
020 |a 9781838810757 
020 |a 9781838810733 
020 |a intechopen.87623 
020 |a 9781838810740 
100 1 |a Mohite, Prashant 
245 0 0 |a Cystic Fibrosis  |h Elektronische Ressource  |b Facts, Management and Advances 
260 |b IntechOpen  |c 2021 
300 |a 1 electronic resource (124 p.) 
653 |a Respiratory medicine / bicssc 
653 |a epidemiology, gene therapy, insulin, screening, glucose, crispr/cas9 
700 1 |a Reed, Anna 
700 1 |a Simon, André R. 
700 1 |a Mohite, Prashant 
041 0 7 |a eng  |2 ISO 639-2 
989 |b DOAB  |a Directory of Open Access Books 
500 |a Creative Commons (cc), https://creativecommons.org/licenses/by/3.0/ 
024 8 |a 10.5772/intechopen.87623 
856 4 0 |u https://mts.intechopen.com/storage/books/9815/authors_book/authors_book.pdf  |7 0  |x Verlag  |3 Volltext 
856 4 2 |u https://directory.doabooks.org/handle/20.500.12854/131035  |z DOAB: description of the publication 
082 0 |a 610 
520 |a Cystic fibrosis, a genetic disorder in children and young adults, is a multisystemic disease that mainly affects the lungs. Advances and improvements in the diagnosis and management of this condition have led to increased overall and symptom-free survival in cystic fibrosis patients. This book examines recent advances in the field and presents an evidence-based approach to the management of cystic fibrosis.